These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14654353)

  • 1. Long-term treatment of Barth syndrome with pantothenic acid: a retrospective study.
    Rugolotto S; Prioli MD; Toniolo D; Pellegrino P; Catuogno S; Burlina AB
    Mol Genet Metab; 2003 Dec; 80(4):408-11. PubMed ID: 14654353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac and clinical phenotype in Barth syndrome.
    Spencer CT; Bryant RM; Day J; Gonzalez IL; Colan SD; Thompson WR; Berthy J; Redfearn SP; Byrne BJ
    Pediatrics; 2006 Aug; 118(2):e337-46. PubMed ID: 16847078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome)-MIM 302060.
    Barth PG; Wanders RJ; Vreken P
    J Pediatr; 1999 Sep; 135(3):273-6. PubMed ID: 10484787
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic analysis of the G4.5 gene in families with suspected Barth syndrome.
    Cantlay AM; Shokrollahi K; Allen JT; Lunt PW; Newbury-Ecob RA; Steward CG
    J Pediatr; 1999 Sep; 135(3):311-5. PubMed ID: 10484795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel missense mutation (R94S) in the TAZ ( G4.5) gene in a Japanese patient with Barth syndrome.
    Sakamoto O; Kitoh T; Ohura T; Ohya N; Iinuma K
    J Hum Genet; 2002; 47(5):229-31. PubMed ID: 12032589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts.
    Valianpour F; Wanders RJ; Overmars H; Vreken P; Van Gennip AH; Baas F; Plecko B; Santer R; Becker K; Barth PG
    J Pediatr; 2002 Nov; 141(5):729-33. PubMed ID: 12410207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilated cardiomyopathy due to type II X-linked 3-methylglutaconic aciduria: successful treatment with pantothenic acid.
    Ostman-Smith I; Brown G; Johnson A; Land JM
    Br Heart J; 1994 Oct; 72(4):349-53. PubMed ID: 7833193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple transmissions of Barth syndrome through an oocyte donor with a de novo TAZ mutation.
    Kirwin SM; Vinette KM; Schwartz SB; Funanage VL; Gonzalez IL
    Fertil Steril; 2007 Apr; 87(4):976.e5-7. PubMed ID: 17241629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria.
    Kelley RI; Cheatham JP; Clark BJ; Nigro MA; Powell BR; Sherwood GW; Sladky JT; Swisher WP
    J Pediatr; 1991 Nov; 119(5):738-47. PubMed ID: 1719174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital neutropenia.
    Christensen RD; Calhoun DA
    Clin Perinatol; 2004 Mar; 31(1):29-38. PubMed ID: 15183654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilated Cardiomyopathy in a 2-Year-Old Infant.
    Peake RW; Daly KP
    Clin Chem; 2017 Jan; 63(1):433-435. PubMed ID: 28062634
    [No Abstract]   [Full Text] [Related]  

  • 12. Barth syndrome is associated with a cognitive phenotype.
    Mazzocco MM; Henry AE; Kelly RI
    J Dev Behav Pediatr; 2007 Feb; 28(1):22-30. PubMed ID: 17353728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients.
    McKenzie M; Lazarou M; Thorburn DR; Ryan MT
    J Mol Biol; 2006 Aug; 361(3):462-9. PubMed ID: 16857210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome.
    Spencer CT; Byrne BJ; Gewitz MH; Wechsler SB; Kao AC; Gerstenfeld EP; Merliss AD; Carboni MP; Bryant RM
    Pediatr Cardiol; 2005; 26(5):632-7. PubMed ID: 16235007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic diagnosis of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome in 10 patients.
    Tassone L; Notarangelo LD; Bonomi V; Savoldi G; Sensi A; Soresina A; Smith CI; Porta F; Plebani A; Notarangelo LD; Badolato R
    J Allergy Clin Immunol; 2009 May; 123(5):1170-3, 1173.e1-3. PubMed ID: 19321197
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiomyopathy in a child with neutropenia and motor delay.
    McCanta AC; Chang AC; Weiner K
    Curr Opin Pediatr; 2008 Oct; 20(5):605-7. PubMed ID: 18781126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label use of granulocyte colony-stimulating factor in noncongenital neutropenia: retrospective data from the Italian Neutropenia Registry.
    Fioredda F; Calvillo M; Renga D; Bonanomi S; Ciliberti A; Martire B; Ghilardi R; Dufour C
    Pediatr Hematol Oncol; 2008 Jun; 25(4):371-4. PubMed ID: 18484485
    [No Abstract]   [Full Text] [Related]  

  • 18. Heart transplantation for Barth syndrome.
    Adwani SS; Whitehead BF; Rees PG; Morris A; Turnball DM; Elliott MJ; de Leval MR
    Pediatr Cardiol; 1997; 18(2):143-5. PubMed ID: 9049131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation in the G4.5 (TAZ) gene in a kindred with Barth syndrome.
    Vesel S; Stopar-Obreza M; Trebusak-Podkrajsek K; Jazbec J; Podnar T; Battelino T
    Eur J Hum Genet; 2003 Jan; 11(1):97-101. PubMed ID: 12529714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor.
    Wandt H; Seifert M; Falge C; Gallmeier WM
    Ann Hematol; 1993 May; 66(5):265-6. PubMed ID: 7685194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.